Lyell Immunopharma, Inc.(LYEL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LYEL Lyell Immunopharma, Inc.

休市中 02-06 16:00:00 EST

22.71

+0.07

+0.31%

盘后22.71

+0.000.00%

16:10 EST

最高23.73	最低22.30	成交量12.46万
今开22.65	昨收22.64	日振幅6.32%
总市值4.82亿	流通市值3.19亿	总股本2,122万
成交额286.04万	换手率0.89%	流通股本1,404万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LYEL","market":"US","secType":"STK","nameCN":"Lyell Immunopharma, Inc.","latestPrice":22.71,"timestamp":1770411600000,"preClose":22.64,"halted":0,"volume":124585,"hourTrading":{"tag":"盘后","latestPrice":22.71,"preClose":22.71,"latestTime":"16:10 EST","volume":2974,"amount":67539.54,"timestamp":1770412204879,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.003091872791519447,"floatShares":14044900,"shares":21218200,"eps":-22.75,"marketStatus":"休市中","change":0.07,"latestTime":"02-06 16:00:00 EST","open":22.65,"high":23.73,"low":22.3,"amount":2860391.11809,"amplitude":0.063163,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-22.75,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"listingDate":1623902400000,"exchange":"NASDAQ","adjPreClose":22.64,"preHourTrading":{"tag":"盘前","latestPrice":23,"preClose":22.64,"latestTime":"06:03 EST","volume":50,"amount":1150,"timestamp":1770375807694,"change":0.36,"changeRate":0.015901,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":22.71,"preClose":22.71,"latestTime":"16:10 EST","volume":2974,"amount":67539.54,"timestamp":1770412204879,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3518161669082376,"impliedVol":0.514,"impliedVolPercentile":0.284},"requestUrl":"/m/hq/s/LYEL","defaultTab":"news","newsList":[{"id":"2595723519","title":"Lyell Immunopharma, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595723519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595723519?lang=zh_cn&edition=full","pubTime":"2025-12-30 23:20","pubTimestamp":1767108023,"startTime":"0","endTime":"0","summary":"北京时间2025年12月30日23时20分，Lyell Immunopharma, Inc.股票出现波动，股价快速下跌5.13%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Cdt Equity Inc C/Wts 22/09/2028、Dermata Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Dermata Therapeutics, Inc.、Gri Bio, Inc.、Theriva Biologics, Inc.较为活跃，换手率分别为1745.05%、611.82%、38.17%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为37.47%、37.42%、30.29%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230232023a48ae223&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230232023a48ae223&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LYEL","BK4139","BK4539"],"gpt_icon":0},{"id":"1151565275","title":"Lyell Immunopharma, Inc.：H.C. Wainwright调高评级至买入，并将目标价上调至45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1151565275","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151565275?lang=zh_cn&edition=full","pubTime":"2025-12-09 19:17","pubTimestamp":1765279051,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma, Inc.：H.C. Wainwright调高评级至买入，并将目标价上调至45美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","LYEL","BK4139","BK4539"],"gpt_icon":0},{"id":"1190850669","title":"Lyell Immunopharma 在第67届 ASH 年会中展示 Ronde-Cel 正在进行的试验新临床数据，显示大B细胞淋巴瘤患者中具有高比例的持久完全缓解","url":"https://stock-news.laohu8.com/highlight/detail?id=1190850669","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190850669?lang=zh_cn&edition=full","pubTime":"2025-12-08 05:32","pubTimestamp":1765143129,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma 在第67届 ASH 年会中展示 Ronde-Cel 正在进行的试验新临床数据，显示大B细胞淋巴瘤患者中具有高比例的持久完全缓解","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4505","BK4139","LYEL"],"gpt_icon":0},{"id":"1166898982","title":"Lyell Immunopharma拟申请Innovative Cellular Therapeutics Holdings Limited不定期转售最多190万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1166898982","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166898982?lang=zh_cn&edition=full","pubTime":"2025-12-06 05:40","pubTimestamp":1764970814,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma拟申请Innovative Cellular Therapeutics Holdings Limited不定期转售最多190万股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LYEL","BK4505","BK4139"],"gpt_icon":0},{"id":"2582345927","title":"Lyell Immunopharma, Inc.盘中异动 快速下挫8.99%报16.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582345927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582345927?lang=zh_cn&edition=full","pubTime":"2025-11-11 22:30","pubTimestamp":1762871439,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日22时30分，Lyell Immunopharma, Inc.股票出现波动，股价大幅下挫8.99%。截至发稿，该股报16.09美元/股，成交量832股，换手率0.00%，振幅4.92%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Quoin Pharmaceuticals Ltd、Engene Holdings Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Quoin Pharmaceuticals Ltd、Aspire Biopharma Holdings, Inc.、Galecto, Inc.较为活跃，换手率分别为1495.39%、258.01%、108.57%，振幅较大的相关个股有Quoin Pharmaceuticals Ltd、Lyell Immunopharma, Inc.、Inflarx N.V.，振幅分别为14.13%、9.67%、7.59%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111223039a49a1717&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111223039a49a1717&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LYEL","BK4539","BK4505"],"gpt_icon":0},{"id":"1177259320","title":"Lyell Immunopharma：根据协议，额外现金对价包括高达6.75亿美元的商业销售里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1177259320","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177259320?lang=zh_cn&edition=full","pubTime":"2025-11-10 20:37","pubTimestamp":1762778235,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma：根据协议，额外现金对价包括高达6.75亿美元的商业销售里程碑","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LYEL","BK4505","BK4139"],"gpt_icon":0},{"id":"1110997827","title":"Lyell Immunopharma：根据协议，额外现金考虑包括3000万美元的临床里程碑和最高1.15亿美元的晚期监管里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1110997827","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110997827?lang=zh_cn&edition=full","pubTime":"2025-11-10 20:37","pubTimestamp":1762778232,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma：根据协议，额外现金考虑包括3000万美元的临床里程碑和最高1.15亿美元的晚期监管里程碑","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","BK4505","LYEL"],"gpt_icon":0},{"id":"1146784437","title":"Lyell Immunopharma, Inc.预计2025年净现金使用将在1.55亿至1.6亿美元之间，不包括交易中4000万美元的预付款","url":"https://stock-news.laohu8.com/highlight/detail?id=1146784437","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146784437?lang=zh_cn&edition=full","pubTime":"2025-11-10 20:32","pubTimestamp":1762777945,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma, Inc.预计2025年净现金使用将在1.55亿至1.6亿美元之间，不包括交易中4000万美元的预付款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4505","BK4139","LYEL"],"gpt_icon":0},{"id":"1165630662","title":"Lyell Immunopharma获得用于转移性结直肠癌临床开发的下一代CAR T细胞产品候选药物的全球独家权利","url":"https://stock-news.laohu8.com/highlight/detail?id=1165630662","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165630662?lang=zh_cn&edition=full","pubTime":"2025-11-10 20:32","pubTimestamp":1762777934,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma获得用于转移性结直肠癌临床开发的下一代CAR T细胞产品候选药物的全球独家权利","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","BK4539","LYEL"],"gpt_icon":0},{"id":"1138858571","title":"Lyell在第67届ASH年会及博览会上宣布Ronde-Cel治疗侵袭性大B细胞淋巴瘤的1/2期临床试验的两项口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1138858571","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138858571?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:01","pubTimestamp":1762178507,"startTime":"0","endTime":"0","summary":"Lyell在第67届ASH年会及博览会上宣布Ronde-Cel治疗侵袭性大B细胞淋巴瘤的1/2期临床试验的两项口头报告","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYEL","BK4139","BK4505","BK4539"],"gpt_icon":0},{"id":"2577302944","title":"Lyell Immunopharma, Inc.盘中异动 急速下挫6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577302944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577302944?lang=zh_cn&edition=full","pubTime":"2025-10-22 22:47","pubTimestamp":1761144463,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日22时47分，Lyell Immunopharma, Inc.股票出现波动，股价快速下挫6.35%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Adaptimmune Therapeutics Plc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Engene Holdings Inc C/Wts 31/10/2028  Cl A涨幅较大，Adaptimmune Therapeutics Plc、Rani Therapeutics Holdings, Inc.、Minerva Neurosciences, Inc较为活跃，换手率分别为85.90%、80.75%、31.63%，振幅较大的相关个股有Adaptimmune Therapeutics Plc、Apollomics Inc C/Wts 01/04/2028 、Rani Therapeutics Holdings, Inc.，振幅分别为73.25%、29.17%、28.77%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102222474394d7f6d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102222474394d7f6d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BK4539","LYEL"],"gpt_icon":0},{"id":"2570880555","title":"Lyell Immunopharma, Inc.盘中异动 临近收盘大幅下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570880555","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570880555?lang=zh_cn&edition=full","pubTime":"2025-09-26 03:50","pubTimestamp":1758829857,"startTime":"0","endTime":"0","summary":"北京时间2025年09月26日03时50分，Lyell Immunopharma, Inc.股票出现异动，股价快速下跌5.13%。截至发稿，该股报12.76美元/股，成交量2.4865万股，换手率0.13%，振幅3.05%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.15%。其相关个股中，Pepgen Inc.、Scisparc Ltd.、Briacell Therapeutics Corp C/Wts 26/02/2026涨幅较大，Scisparc Ltd.、Evaxion A/S、Qualigen Therapeutics, Inc.较为活跃，换手率分别为5443.80%、1207.91%、739.13%，振幅较大的相关个股有Scisparc Ltd.、Geovax Labs Inc C/Wts 29/09/2025、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为95.30%、86.27%、58.88%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926035058a4441c24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926035058a4441c24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4505","BK4139","LYEL"],"gpt_icon":0},{"id":"1171858003","title":"Lyell Immunopharma宣布启动3期头对头CAR-T细胞疗法临床试验 针对侵袭性大B细胞淋巴瘤并成立专家指导委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=1171858003","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171858003?lang=zh_cn&edition=full","pubTime":"2025-09-03 20:00","pubTimestamp":1756900844,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma近日宣布，该公司已正式启动一项3期头对头CAR-T细胞疗法临床试验，该试验专门针对侵袭性大B细胞淋巴瘤患者。与此同时，公司还宣布成立了专家指导委员会，为这一重要临床研究提供专业指导。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LYEL","BK4505","BK4139"],"gpt_icon":0},{"id":"2558661655","title":"Lyell Immunopharma, Inc.盘中异动 快速跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558661655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558661655?lang=zh_cn&edition=full","pubTime":"2025-08-11 22:51","pubTimestamp":1754923876,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日22时51分，Lyell Immunopharma, Inc.股票出现波动，股价快速下挫5.05%。截至发稿，该股报10.43美元/股，成交量1.4935万股，换手率0.08%，振幅3.37%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Entero Therapeutics Inc.、Equillium, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5143.13%、413.01%、158.05%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为84.05%、74.27%、54.40%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811225117a4823485&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811225117a4823485&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LYEL","BK4505","BK4539"],"gpt_icon":0},{"id":"2557936385","title":"Lyell Immunopharma, Inc.盘中异动 股价大涨5.60%报11.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557936385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557936385?lang=zh_cn&edition=full","pubTime":"2025-08-08 02:39","pubTimestamp":1754591991,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日02时39分，Lyell Immunopharma, Inc.股票出现波动，股价急速上涨5.60%。截至发稿，该股报11.70美元/股，成交量2.8761万股，换手率0.15%，振幅6.14%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808023951a47b8330&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808023951a47b8330&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LYEL","BK4505","BK4139"],"gpt_icon":0},{"id":"2557233546","title":"Lyell Immunopharma, Inc.盘中异动 快速上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557233546","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557233546?lang=zh_cn&edition=full","pubTime":"2025-08-05 02:14","pubTimestamp":1754331296,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日02时14分，Lyell Immunopharma, Inc.股票出现波动，股价急速上涨5.22%。截至发稿，该股报11.60美元/股，成交量1.8256万股，换手率0.10%，振幅5.35%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.36%。其相关个股中，Psyence Biomedical Ltd.、Bioxcel Therapeutics, Inc.、凯信远达涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为6236.97%、1453.63%、809.30%，振幅较大的相关个股有凯信远达、Psyence Biomedical Ltd.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为92.95%、84.21%、80.73%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080502145694cf6184&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080502145694cf6184&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BK4539","LYEL"],"gpt_icon":0},{"id":"2556480588","title":"Lyell Immunopharma, Inc.盘中异动 股价大跌5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556480588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556480588?lang=zh_cn&edition=full","pubTime":"2025-08-02 01:58","pubTimestamp":1754071116,"startTime":"0","endTime":"0","summary":"北京时间2025年08月02日01时58分，Lyell Immunopharma, Inc.股票出现波动，股价大幅下跌5.76%。截至发稿，该股报11.13美元/股，成交量7875股，换手率0.04%，振幅2.92%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Equillium, Inc.、Sensei Biotherapeutics, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Bioxcel Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.、Soligenix, Inc.较为活跃，换手率分别为1729.02%、282.18%、201.50%，振幅较大的相关个股有Equillium, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、天境生物，振幅分别为99.69%、72.18%、58.71%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802015836a6ce372a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802015836a6ce372a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4505","LYEL"],"gpt_icon":0},{"id":"2556283080","title":"Lyell Immunopharma, Inc.盘中异动 下午盘急速下挫5.23%报11.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556283080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556283080?lang=zh_cn&edition=full","pubTime":"2025-08-01 01:26","pubTimestamp":1753982764,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日01时26分，Lyell Immunopharma, Inc.股票出现波动，股价急速跳水5.23%。截至发稿，该股报11.79美元/股，成交量1.5668万股，换手率0.08%，振幅5.63%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为2.58%。其相关个股中，Soligenix, Inc.、Silexion Therapeutics Corp、Onconetix, Inc.涨幅较大，Soligenix, Inc.、Psyence Biomedical Ltd.、Onconetix, Inc.较为活跃，换手率分别为10413.79%、5077.34%、4846.39%，振幅较大的相关个股有Soligenix, Inc.、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为297.60%、97.88%、97.44%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801012604972ab9f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801012604972ab9f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LYEL","BK4505","BK4139"],"gpt_icon":0},{"id":"2555052547","title":"Lyell Immunopharma, Inc.盘中异动 早盘股价大跌5.24%报13.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555052547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555052547?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:48","pubTimestamp":1753796920,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时48分，Lyell Immunopharma, Inc.股票出现异动，股价大幅下跌5.24%。截至发稿，该股报13.01美元/股，成交量1.2409万股，换手率0.07%，振幅5.89%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Calidi Biotherapeutics, Inc.、Scinai Immunotherapeutics Ltd涨幅较大，Scinai Immunotherapeutics Ltd、Tnf Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为3360.17%、1307.28%、359.46%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Scinai Immunotherapeutics Ltd、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为45.70%、43.41%、35.89%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729214840a469cdbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729214840a469cdbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LYEL","BK4539","BK4505"],"gpt_icon":0},{"id":"2554577759","title":"Lyell Immunopharma, Inc.盘中异动 大幅上涨5.15%报13.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554577759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554577759?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:30","pubTimestamp":1753709446,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时30分，Lyell Immunopharma, Inc.股票出现波动，股价大幅拉升5.15%。截至发稿，该股报13.06美元/股，成交量8300股，换手率0.04%，振幅2.50%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Celcuity Inc.、Aim Immunotech Inc.、Cervomed Inc.涨幅较大，Aim Immunotech Inc.、Cervomed Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为213.64%、80.03%、79.76%，振幅较大的相关个股有Celcuity Inc.、Aim Immunotech Inc.、Mersana Therapeutics, Inc.，振幅分别为23.86%、15.47%、8.31%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072821304694bf6e42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072821304694bf6e42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LYEL","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lyell.com","stockEarnings":[{"period":"1week","weight":-0.0537},{"period":"1month","weight":-0.0934},{"period":"3month","weight":0.297},{"period":"6month","weight":1.0683},{"period":"1year","weight":0.9213},{"period":"ytd","weight":-0.2622}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lyell Immunopharma, Inc.于2018年6月在特拉华州注册成立。该公司是一家临床阶段细胞治疗公司，预计将于2025年进入关键试验，并推进用于血液系统恶性肿瘤和实体瘤患者的专有下一代自体嵌合抗原受体T细胞候选产品管线。该公司正在开创新的方法，旨在产生驱动持久临床反应的T细胞。患者的活细胞是公司研究性CAR T细胞疗法的起点，公司通过创新的CAR结构、技术和制造协议增强。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.135683},{"month":2,"riseRate":0.6,"avgChangeRate":0.13563},{"month":3,"riseRate":0.25,"avgChangeRate":-0.171055},{"month":4,"riseRate":0.25,"avgChangeRate":-0.066906},{"month":5,"riseRate":0.5,"avgChangeRate":0.143482},{"month":6,"riseRate":0.5,"avgChangeRate":0.026837},{"month":7,"riseRate":0.4,"avgChangeRate":0.020455},{"month":8,"riseRate":0.4,"avgChangeRate":-0.008473},{"month":9,"riseRate":0.4,"avgChangeRate":0.012765},{"month":10,"riseRate":0.4,"avgChangeRate":-0.081669},{"month":11,"riseRate":0.4,"avgChangeRate":-0.025774},{"month":12,"riseRate":0.4,"avgChangeRate":-0.056847}],"exchange":"NASDAQ","name":"Lyell Immunopharma, Inc.","nameEN":"Lyell Immunopharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lyell Immunopharma, Inc.(LYEL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lyell Immunopharma, Inc.(LYEL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lyell Immunopharma, Inc.,LYEL,Lyell Immunopharma, Inc.股票,Lyell Immunopharma, Inc.股票老虎,Lyell Immunopharma, Inc.股票老虎国际,Lyell Immunopharma, Inc.行情,Lyell Immunopharma, Inc.股票行情,Lyell Immunopharma, Inc.股价,Lyell Immunopharma, Inc.股市,Lyell Immunopharma, Inc.股票价格,Lyell Immunopharma, Inc.股票交易,Lyell Immunopharma, Inc.股票购买,Lyell Immunopharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lyell Immunopharma, Inc.(LYEL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lyell Immunopharma, Inc.(LYEL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}